from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1818c/PE_PGRS33

LFCtreatmentdescriptionclass of inhibitor

0.140

Amikacinug/mL Amikacintranslation

-0.200

Cap5-10ug/mL Capreomycintranslation

1.331

Rox10-50 ug/mL Roxithromycintranslation

-0.367

SM2-5 ug/mL Streptomycintranslation

1.442

Tet5-10 ug/mL Tetracyclinetranslation

-0.211

Rif0.2-5ug/mL Rifampicintranscription

-1.855

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.910

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.260

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.086

CPZ10-50 ug/mL Chlorpromazinerespiration

0.607

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.562

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.629

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.648

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.985

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.407

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.110

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.329

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.637

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.197

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.058

KCN5-20 ug/mL Potassium cyaniderespiration

0.270

NaN30.2-2 mM Sodium aziderespiration

-0.207

Nigericin50 uM Nigericinrespiration

0.195

TRC10-150 ug/mL Triclosanrespiration

1.640

TRZ10-25 ug/mL Thioridazinerespiration

0.178

Valinomycin0.5-10 uM Valinomycinrespiration

-1.046

ZnSO42 mM ZnSO4respiration

-0.069

menadione6-10 ug/mL Menadionerespiration

-0.062

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-1.222

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.115

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.771

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.060

NRP_1Non-replicating persistence stage 1dosRassociated

-0.212

Amp0.2mg/mL AmpicillincellWall

0.156

Cephalexin20-100 ug/mL CephalexincellWall

-0.974

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.958

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.468

EMB10-20 ug/mL EthambutolcellWall

-0.499

Eta12-40 ug/mL EthionamidecellWall

-0.329

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.144

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.308

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.984

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.430

BZA0.12 mg/mL BenzamidearomaticAmides

-0.237

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.070

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.158

H2O24 mM hydrogen peroxideDNAdamaging

-0.842

Levo10 ug/mL LevofloxacinDNAdamaging

-0.634

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.435

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.110

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.373

UVUV-irradiationDNAdamaging

1.477

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.323

Antimycin12.5-50 ug/mL Antimycin A?

-1.147

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.229

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.534

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.837

PA8240.2-2 ug/mL PA-824?

0.922

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.386

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.744

Verapamil50 uM Verapamil?

-0.186

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.372

methoxatin10-20 ug/mL Methoxatin?